Education
About Us
Working with TipRanks
Follow Us
Silo Pharma Inc (SILO)
:SILO
SILO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.41 - $4.50
Previous CloseN/A
Volume152.45M
Average Volume (3M)1.78M
Market Cap
$4.35M
Enterprise Value-$3.69M
Total Cash (Recent Filing)$5.45M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.38
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.14
Shares Outstanding7,207,792
10 Day Avg. Volume4,035,726
30 Day Avg. Volume1,780,719
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.74
Price to Sales (P/S)0.00
P/FCF Ratio-2.19
Enterprise Value/Market Cap-0.85
Enterprise Value/Revenue-12.80
Enterprise Value/Gross Profit-55.72
Enterprise Value/Ebitda0.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Silo Pharma News
PremiumCompany Announcements
Silo Pharma Completes Public Offering, Raises $1.56 Million
Options Prices
Currently, No data available
---
Ownership Overview
2.82% Insiders
0.70% Mutual Funds
2.00% Other Institutional Investors
91.70% Public Companies and Individual Investors
SILO FAQ
What was Silo Pharma Inc’s price range in the past 12 months?
Silo Pharma Inc lowest stock price was $0.41 and its highest was $4.50 in the past 12 months.
What is Silo Pharma Inc’s market cap?
Silo Pharma Inc’s market cap is $4.35M.
When is Silo Pharma Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Silo Pharma Inc’s earnings last quarter?
Silo Pharma Inc released its earnings results on Nov 11, 2021. The company reported $3.202 earnings per share for the quarter, beating the consensus estimate of N/A by $3.202.
Is Silo Pharma Inc overvalued?
According to Wall Street analysts Silo Pharma Inc’s price is currently Overvalued.
Does Silo Pharma Inc pay dividends?
Silo Pharma Inc does not currently pay dividends.
What is Silo Pharma Inc’s EPS estimate?
Silo Pharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Silo Pharma Inc have?
Silo Pharma Inc has 7,207,792 shares outstanding.
What happened to Silo Pharma Inc’s price movement after its last earnings report?
Silo Pharma Inc reported an EPS of $3.202 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Silo Pharma Inc?
Currently, no hedge funds are holding shares in SILO
Company Description
Silo Pharma Inc
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
Technical Analysis
180 Life Sciences
―
Creative Medical Technology Holdings
―
Alzamend Neuro
―
Longevity Health Holdings
―
Klotho Neurosciences
―